Bank of America
VYGR icon

Bank of America’s Voyager Therapeutics VYGR Stock Holding History

Bank of America’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Sell
45,245
-62,186
-58% -$236K ﹤0.01% 5448
2026
Q1 		$415K Sell
107,431
-68,666
-39% -$270K ﹤0.01% 5000
2025
Q4 		$692K Sell
176,097
-251,333
-59% -$1.11M ﹤0.01% 4725
2025
Q3 		$2M Sell
427,430
-149,052
-26% -$539K ﹤0.01% 4824
2025
Q2 		$1.79M Sell
576,482
-103,794
-15% -$335K ﹤0.01% 4872
2025
Q1 		$2.3M Buy
680,276
+661,504
+3,524% +$3.09M ﹤0.01% 4561
2024
Q4 		$106K Sell
18,772
-512,785
-96% -$3.31M ﹤0.01% 6371
2024
Q3 		$3.11M Sell
531,557
-117,203
-18% -$852K ﹤0.01% 4181
2024
Q2 		$5.13M Buy
648,760
+294,317
+83% +$2.47M ﹤0.01% 3591
2024
Q1 		$3.3M Buy
354,443
+346,741
+4,502% +$2.93M ﹤0.01% 4020
2023
Q4 		$65K Sell
7,702
-132,195
-94% -$959K ﹤0.01% 6528
2023
Q3 		$1.08M Buy
139,897
+112,395
+409% +$1.03M ﹤0.01% 4766
2023
Q2 		$315K Sell
27,502
-20,127
-42% -$208K ﹤0.01% 5557
2023
Q1 		$367K Buy
47,629
+31,380
+193% +$250K ﹤0.01% 5570
2022
Q4 		$99.1K Buy
16,249
+3,034
+23% +$17.2K ﹤0.01% 6239
2022
Q3 		$78K Sell
13,215
-26,175
-66% -$168K ﹤0.01% 6470
2022
Q2 		$233K Sell
39,390
-48,477
-55% -$327K ﹤0.01% 5976
2022
Q1 		$669K Buy
87,867
+75,666
+620% +$338K ﹤0.01% 5598
2021
Q4 		$33K Sell
12,201
-23,709
-66% -$80.9K ﹤0.01% 7373
2021
Q3 		$94K Buy
35,910
+6,014
+20% +$19.5K ﹤0.01% 6757
2021
Q2 		$124K Buy
29,896
+7,640
+34% +$34.6K ﹤0.01% 6400
2021
Q1 		$104K Buy
22,256
+8,890
+67% +$60.6K ﹤0.01% 6370
2020
Q4 		$96K Sell
13,366
-27,783
-68% -$267K ﹤0.01% 6009
2020
Q3 		$438K Buy
41,149
+18,648
+83% +$219K ﹤0.01% 4810
2020
Q2 		$284K Sell
22,501
-14,490
-39% -$169K ﹤0.01% 5014
2020
Q1 		$338K Buy
36,991
+25,096
+211% +$288K ﹤0.01% 4784
2019
Q4 		$166K Sell
11,895
-77,828
-87% -$1.13M ﹤0.01% 5732
2019
Q3 		$1.54M Buy
89,723
+25,049
+39% +$526K ﹤0.01% 4246
2019
Q2 		$1.76M Buy
64,674
+29,121
+82% +$666K ﹤0.01% 4127
2019
Q1 		$680K Buy
35,553
+24,916
+234% +$325K ﹤0.01% 4808
2018
Q4 		$100K Buy
10,637
+7,217
+211% +$92.6K ﹤0.01% 5919
2018
Q3 		$65K Sell
3,420
-22,626
-87% -$434K ﹤0.01% 6089
2018
Q2 		$509K Buy
26,046
+17,580
+208% +$347K ﹤0.01% 4896
2018
Q1 		$159K Buy
8,466
+255
+3% +$5.51K ﹤0.01% 5497
2017
Q4 		$136K Buy
8,211
+7,116
+650% +$122K ﹤0.01% 5600
2017
Q3 		$23K Buy
1,095
+371
+51% +$4.19K ﹤0.01% 6226
2017
Q2 		$6K Sell
724
-5,385
-88% -$54.2K ﹤0.01% 6563
2017
Q1 		$81K Buy
6,109
+117
+2% +$1.42K ﹤0.01% 5718
2016
Q4 		$76K Buy
5,992
+1,437
+32% +$18.5K ﹤0.01% 5748
2016
Q3 		$55K Buy
4,555
+12
+0.3% +$162 ﹤0.01% 5695
2016
Q2 		$50K Buy
4,543
+4,083
+888% +$50K ﹤0.01% 5840
2016
Q1 		$4K Buy
460
+321
+231% +$3.64K ﹤0.01% 6651
2015
Q4 		$3K Buy
+139
New +$3.2K ﹤0.01% 7032

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of America's VYGR Position: Q2 2026 in Review

Bank of America reduced its Voyager Therapeutics (VYGR) stake by 58% in Q2 2026, selling an estimated $236K and leaving 45,245 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #5448.

Bank of America first reported a position in VYGR in Q4 2015 and has held it in 43 quarters since. The position peaked at $5.13M in Q2 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Bank of America held 45,245 shares of Voyager Therapeutics worth $158K as of Q2 2026.
  • Bank of America sold 62,186 Voyager Therapeutics shares in Q2 2026, an estimated $236K.
  • Voyager Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5448 holding.
  • Bank of America first reported a position in Voyager Therapeutics in Q4 2015 and has held it in 43 quarters since.
  • Bank of America's Voyager Therapeutics position peaked at $5.13M in Q2 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.